Clinical Trials Sponsored by BMG PHARMA

Total 8577 results

University of Milan
BMG Pharma

Unknown

Effect of a Hydrogen-Peroxide and Hyaluronic-Acid Mouthwash (BMG0703) in the Treatment of Periodontitis

Periodontitis | Bleeding Gum | Pocket, Periodontal

Italy
University of Milan
BMG Pharma

Unknown

Evaluation of Hydrogen Peroxide and Hyaluronic Acid (BMG0703) in the Healing of Post-extraction Sites

Impacted Third Molar Tooth | Healing Surgical Wounds

Italy
BMG Pharma
Opera CRO, a TIGERMED Group Company

Completed

Evaluation of Safety and Performance of Ialuxid Gel in Treatment of Acne Vulgaris, Impetigo and Folliculitis

Acne Vulgaris | Folliculitis | Impetigo

Romania
PMG Pharm Co., Ltd

Completed

To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients

Osteoarthritis of the Knee

Korea, Republic of
PMG Pharm Co., Ltd

Recruiting

A Phase 3 Study to Assess the Efficacy and Safety of PK101 in Patients With Knee Osteoarthritis

Knee Osteoarthritis

Korea, Republic of
PMG Pharm Co., Ltd

Completed

Drug-Drug Interaction Between PK101-001 and PK101-002

Arthritis

Korea, Republic of
PMG Pharm Co., Ltd

Completed

To Compare the Efficacy and Safety of LAYLA in Osteoarthritis Patients of the Knee

Osteoarthritis of the Knee

Korea, Republic of
PMG Pharm Co., Ltd

Completed

Study to Compare the Safety and Pharmacokinetics of PK101 With Coadministration of the Two Separate Drugs

Arthritis

Korea, Republic of
PMG Pharm Co., Ltd

Completed

Active Drug Comparative, Multi-center, phase3 Clinical Study to Evaluate the Efficacy and Safety of PG201 in Osteoarthritis Patients

Osteoarthritis of the Knee

Korea, Republic of
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
The BMJ

Completed

The Effect of Different Financial Competing Interest Statements on Readers' Perceptions of Clinical Educational Articles

Healthy
BMI Healthcare

Unknown

Nerve Block Versus Non-targeted Local Anaesthesia in Breast Surgery

Pain, Post Operative

United Kingdom
BMI Korea

Completed

Evaluate the Safety and Tolerability of a Single-dose Administration of BMI2004 Inj.

Health, Subjective

Korea, Republic of
BMI Korea

Completed

Treatment of Moderate to Severe Glabellar Lines (BMI2006) (BMI2006)

Glabellar Lines

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
BTG International Inc.

Completed

Retrospective Evaluation of CroFab - Efficacy in Severe Envenomation

Snake Envenomation

United States
BTG International Inc.

Completed

Copperhead Envenomation Observational Study

Copperhead Snake Envenomation

United States
BMI Southend Hospital

Unknown

Visual Performance With a Trifocal Intraocular Lens

Cataract

United Kingdom
Clinica Olivos SMG

Not yet recruiting

Airway Occlusion Measured During Non-invasive Ventilation to Assess Respiratory Effort

Healthy Volunteers

Argentina
Big Health Inc.

Completed

Rise Study for Depression

Major Depressive Disorder

United States
BTG International Inc.

Completed

Open-label Safety and Tolerability Study of CoVaccine HT™ in Healthy Volunteers

Vaccine

United Kingdom
BTG International Inc.

Terminated

Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma

Hepatocellular Carcinoma

Belgium
BTG International Inc.

Completed

Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze (LVPK)

Lymphoma | Leukemia | Osteosarcoma

United States
BTG International Inc.

Completed

Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation (Copperhead)

Snake Bites

United States
BTG International Inc.

Completed

Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance

Neoplasms

Germany
ProgenaBiome
Big Corona Ltd.

Withdrawn

A Study of Combination Therapies to Treat COVID-19 Infection

COVID-19 | Coronavirus Infection | SARS-CoV 2 | COVID | Corona Virus Infection | SARS Pneumonia | Coronavirus-19 | Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere

United States
BTG International Inc.
Encorium

Terminated

Safety and Efficacy Study of Angiotensin Therapeutic Vaccine in Subjects With Mild to Moderate Hypertension

Hypertension | Cardiovascular Disease

United Kingdom
PT Sydna Farma
PT Pharma Metric Labs

Completed

Bioequivalence Study of Cyproterone Acetate and Ethinyl Estradiol in Healthy Female Volunteers

Drug Use

Indonesia
Monash University
Caring Pharmacy; Bionime Corporation; Tigas Pharma

Active, not recruiting

Prevention and Treatment of Diabetes in Adults

PreDiabetes

Malaysia
Big Blue Biotech, Inc.

Terminated

A Study of the PedSCath Pediatric Sampling Catheter Versus Current Standard of Care.

Urinary Tract Infections in Children

United States
OhioHealth
BTG International Inc.

Withdrawn

Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs

Leg Ulcer | Varicose Veins | Varicose Ulcer | Venous Leg Ulcer | Venous Reflux | Reflux | Venous Ulcer | Veins, Varicose | Varicose Veins Leg

United States
CMG Pharmaceutical Co. Ltd

Completed

Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers

Schizophrenia
BTG International Inc.
GlaxoSmithKline

Completed

Efficacy Study of Digibind for Treatment of Severe Preeclampsia

Pre-eclampsia

United States
UCB Biopharma S.P.R.L.
Pharm Research Associates (UK) Ltd.

Completed

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (BASE)

Epilepsy With POS With or Without Secondary Generalization

Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
UCB Pharma SA

Completed

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

Epilepsy

United States, Belgium, Czechia, France, Germany, Hungary, Ireland, Italy, Mexico, Poland, Spain, United Kingdom
UCB Pharma SA

Completed

Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

Epilepsy, Partial

Canada, United States
Vifor Pharma, Inc.

Terminated

Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia (EMERALD)

Hyperkalemia

United States, Bulgaria, Canada, Georgia, Germany, Poland, Ukraine
UCB Pharma SA

Completed

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Epilepsy

Belgium, Finland, France, Germany, Hungary, India, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
UCB Pharma SA

Completed

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

Generalized Epilepsy
UCB Pharma SA

Completed

Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)

Dermatitis, Atopic
UCB Pharma SA

Completed

A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] (PRECiSE 3)

Crohn's Disease

United States, Australia, Austria, Belarus, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, Israel, Italy, New Zealand, Norway, Poland, Russian Federation, Serbia, Singapore, Slovenia, South Africa, Spain, Ukraine, Canada and more
NicOx
Theradis pharma; Iris Pharma

Withdrawn

Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240) (Goldeneye)

Adenoviral Conjunctivitis

Spain
UCB Pharma GmbH

Completed

Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy (VICTOS)

Focal Epilepsy With and Without Secondary Generalization

Germany, Austria
UCB Pharma SA

Completed

Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults

Unverricht-Lundborg Disease

France, Italy, Sweden, Finland, Netherlands, Tunisia, Réunion
UCB Pharma SA

Completed

Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects

Healthy Volunteers

United Kingdom
UCB Pharma SA

Terminated

Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease (REFRESH-PD)

Advanced Idiopathic Parkinson's Disease

United Kingdom
Astellas Pharma Inc
Advanz Pharma

Completed

Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter

Atrial Fibrillation | Atrial Flutter

United States, Argentina, Canada, Chile, Denmark, Mexico, Sweden

3

Subscribe